The Association for Reproductive Cancers is dedicated to increasing awareness, advancing research, providing education, and advocating for reproductive cancers affecting both men and women.
​
Our Organization
EW Walton, PhD
CEO, ARC
​
Gail Martin, MD
Vice President, ARC
April Spencer, MD
Thought-Leader, ARC​
Lydia Kashaka
Head of Marketing
​
Help Us Fight Reproductive Cancers
At Chanda’s ARC, we envision a future where reproductive cancers no longer claim lives too soon. Inspired by the legacy of Dr. Chanda Walton, we are on a mission to empower communities through awareness, education, and groundbreaking research—detecting and treating ovarian, prostate, and other reproductive cancers earlier and more effectively. Together, we can transform the future of reproductive health. Your support fuels innovation, saves lives, and brings hope to families everywhere. Join us—give today and help rewrite the story of reproductive cancer.
PREVENTION CAMPAIGN
The Chanda’s ARC Prevention Campaign is dedicated to raising awareness and promoting early detection of reproductive cancers, empowering individuals with knowledge that can save lives. Through educational workshops, community outreach, and digital resources, the campaign focuses on recognizing early symptoms, advocating for routine screenings, and addressing disparities in healthcare access.
Chanda's Run
(March 2026)
The Association for Reproductive Cancers (ARC) is launching 5K+ runs to raise awareness about ovarian cancer and other cancers affecting the reproductive system. These events will not only shine a light on the urgency of early detection and research but also provide crucial support for our members—survivors, families, and advocates—who are fighting for progress. Every step taken brings us closer to breakthroughs, better treatments, and a stronger community. Join us, run with purpose, and make an impact!
RESEARCH
Your contributions will help fund university partnerships dedicated to training the next generation of researchers and enable us to collaborate with Memorial Sloan Kettering (MSK) and other research-based institutions to enhance cutting-edge research focused on ovarian cancer. Together, we are driving innovation, increasing awareness, and working toward life-saving breakthroughs.